You folks were busy last night. Fine’s shenaniga

You folks were busy last night. Fine’s shenanigans has us a little on edge. I’m glad it looks like you worked it out. We have not updated the milestone timeline in a couple months. We have also added new milestones, for example the Nash study now, FDAs answer on the 525mg for Combo, mono pivotal approval, etc. This week I’ll go back and take a look, maybe with everyone’s help we can piece together a new updated list including the tnbc interim results timeline—where I have a couple thought myself on estimating. The first, I’ll have to check, but I believe NP said if they get results on the first 5 people, they will apply for breakthrough. The second is once enrollment starts I’m all the sites, I don’t be that will be an issue. The issue is with the 3+3 design. Once they enroll the first 3, they have to wait either 1 or 2 cycles for safety data, to determine if it is safe to continue at the higher dose. The protocol doesn’t say the number of cycles, but my research I posted here on an expert survey, gave 2 was what the experts feel is best, a few thought 1 and a few thought 3. Anyway during that time, they can be working on setting up enrollment for new patients when the evaluation time is over. But that is the hurdle that slows down the time it takes to get data on the first 5 in my opinion. Maybe we can work out that timeline as well. Today I’m going to a birthday party for my niece at a lake and enjoy this nice weekend and great weather.